Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 yearsHiroo Yokozeki, Haruko Nishie, Takayo Matsumura et al.|British Journal of Dermatology|2024Cited by 18